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 Hormetic dose response occurs for many endpoints associated with exposures of bio-
logical organisms to environmental stressors. Cell-based U- or inverted U-shaped respons-
es may derive from common processes involved in activation of adaptive responses
required to protect cells from stressful environments. These adaptive pathways extend the
region of cellular homeostasis and are protective against ultimate cell, organ, and system
toxicity. However, the activation of stress responses carries a significant energetic cost to
the cell, leading to alterations of a variety of basal cellular functions in adapted or stressed
cells. This tradeoff of resources between the unstressed and adapted states may lead to U-
or inverted U-shaped dose response curves for some precursor endpoints. We examine
this general hypothesis with chlorine, a prototype oxidative stressor, using a combination
of cellular studies with gene expression analysis of response pathways and with computa-
tional modeling of activation of control networks. Discrete cellular states are expected as
a function of exposure concentration and duration. These cellular states include normal
functioning state, adaptive and stressed states at mild to intermediate exposures, and overt
toxicity in the presence of an overwhelming concentration of stressors. These transitions
can be used to refine default risk assessment practices that do not currently accommodate
adaptive responses.
Keywords: Hormesis, adaptive response, homeostasis, oxidative stress, chlorine
BACKGROUND OF HORMESIS
The concept of hormesis encompasses a wide array of nonmonoton-
ic biological responses that are either below or above control levels
depending on the dose of the applied agent (Calabrese and Baldwin
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2001a). Graphically, a hormetic dose response can be either a U- or
inverted U-shaped curve, with the hormetic zone on average spanning a
10- to 20-fold dose range and the peak or nadir response 30-60% above
or below control (Calabrese et al. 2007). The nonmonotonic biological
response was first described in the late 19th century by Schulz who found
that chemical fungicides such as mercuric chloride enhanced yeast
metabolism at low doses but inhibited it at high doses (Schulz 1888). It
wasn’t until the early 1940’s that the term hormesis was formally intro-
duced by Southam and Ehrlich to define similar phenomena (Southam
and Ehrlich 1943). Although by some, hormesis is thought to have a con-
nection with homeopathy, a controversial therapeutic concept believing
that extremely diluted toxicants are beneficial to human health, it is
abundantly clear from accumulating evidence to date that hormesis is a
real biological phenomenon (Calabrese and Baldwin 2001a; Calabrese
and Baldwin 2001b). Hormetic responses have been observed at multiple
levels of biological organizations with many physical/chemical stressors
for a variety of biological endpoints. For example, U- or inverted U-
shaped responses have been observed for DNA damage (Kitchin and
Brown 1994), cellular fate such as proliferation, differentiation, and sur-
vival (Pi et al. 2008a), and for pathological endpoints such as carcinogen-
esis (Kitano et al. 1998). Despite a frequently observed phenomenon,
hormetic dose response is used neither as the default nor as a secondary
model for conducting chemical risk assessments. Application of these
dose response relationships for risk assessment remains problematic
because the biological basis of this phenomenon is not well-character-
ized.
Current efforts to explain nonmonotonic responses including
hormesis suggest that these complex dose response curves may arise from
a variety of mechanisms, depending on both the biological endpoints and
type of inducing agents (Conolly and Lutz 2004). Further, the dose
response for the various endpoints is also a function of time in the patho-
genesis at which the observation occurs, e.g., according to standard toxi-
cological testing sacrifice schedules. The underlying mechanisms for non-
monotonic responses may operate at different levels of the biological
organizations involving interactions between multiple organs/tissues, cell
types, or cellular components. Some biphasic responses occur in systems
in which the input signal affects the endpoint through two parallel yet
functionally opposing processes, each with a different sensitivity. A classic
example of this is the biphasic response of blood vessels to adrenergic
stimulants. At a low concentration, isoproterenol causes dilation of arter-
ies by inhibiting smooth muscle contraction via β-receptors; whereas at a
high concentration, it causes constriction of arteries by stimulating
smooth muscle contraction via α-receptors (Fleisch et al. 1970). In the
context of steroid hormone signaling, we recently proposed that homod-
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imerization of steroid hormone receptors, an inherently nonlinear
process, may be responsible for the nonmonotonic dose responses
observed with certain steroid mimics including endocrine active chemi-
cals and selective steroid receptor modulators (Li et al. 2007). In carcino-
genesis, nonmonotonic relationships may arise from competing process-
es that have opposite effects on tumor formation but different dose
dependencies (Andersen and Conolly 1998). 
Despite the fact that an individual hormetic response may be tied to
a specific cellular or physiological pathway(s) or processes(s), there have
been several efforts made in the past to advance a generally unifying the-
ory for hormesis. One particularly attractive hypothesis centers on the
homeostatic adaptation of a biological system in response to perturba-
tions. A fundamental feature of biological systems is robustness, i.e., the
unusual ability to carry out basic functions nearly unaltered in spite of
various perturbations imposed by changes in the internal or external
environment (Kitano 2004). This robustness is maintained by an array of
homeostatic control systems at both cellular and physiological levels,
which are activated to compensate for perturbations, adapting the bio-
logical organisms to stressful environments. For example, DNA damage
by radiation is an adaptive response in which a variety of DNA repair
enzymes are activated to alleviate further damages by continued exposure
to radiation. Calabrese and others argued that hormesis simply occurs as
a result of overcompensation by the homeostatic control system exposed
to stressors at low doses (Stebbing 1998; Calabrese 2001). While this is an
appealing hypothesis, it remains unclear as to how overcompensation
occurs mechanistically with an adaptive system. Here, we advance a
hypothesis on the manner in which adaptive cellular responses may lead
to hormesis.
ADAPTIVE ANTI-STRESS GENE REGULATORY NETWORK AND CELLULAR
STATE TRANSITION
One aspect of robustness at the cellular level is the maintenance of a
stable intracellular milieu in a constantly changing extracellular environ-
ment. In this context, environmental stressors usually disturb the con-
centrations of important molecular species in the cell that need to be
kept in a tightly controlled range for normal cell function. From an engi-
neering perspective, these molecular species are controlled variables,
examples of which include reactive oxygen species (ROS), DNA adducts,
glucose, and oxygen. To prevent these controlled variables from large
and potentially harmful deviations from their basal operating concentra-
tions, cells possess an array of anti-stress gene regulatory networks each
responsible for handling a particular type of physical/chemical stress,
such as oxidative stress, DNA damage, protein denaturation, and osmot-
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ic stress. These regulatory networks in cells are very complex, often
involving multiple genes, proteins/enzymes, metabolic reactions, pro-
tein/protein and protein/DNA interactions, as exemplified by the
antioxidant stress response (Kensler et al. 2006) and heat shock response
(Kampinga 2006). Despite the vast complexity, most anti-stress gene reg-
ulatory networks can be conceptually viewed as a negative feedback cir-
cuit, which underlies the adaptive responses to many biological stressors
(Fig. 1). An anti-stress gene regulatory network usually contains special-
ized protein molecules which can sense the level of controlled variables,
which can be ROS, misfolded proteins, and DNA adducts, etc. External
stressor-induced initial changes in the level of controlled variables are first
detected by these molecular sensors. The signal is then relayed to activate
specific transcription factors (in some cases the transcription factors them-
selves can serve directly as the sensor molecules). Closing the feedback
loop, activated transcription factors upregulate expression of a suite of
anti-stress genes, which encode metabolic enzymes working coordinately
to counteract the changes in controlled variables brought about by the
perturbing stressors. As a result, within a wide dose range of the stressors,
the steady-state concentrations of controlled variables may not change as
much due to the operation of this homeostatic control mechanism. 
To achieve a robust homeostatic control, i.e., to have a high resistance
to perturbations in order to maintain controlled variables within a tight-
ly regulated range, theoretical work has emphasized the importance of a
high loop gain for a negative feedback-mediated control system. In this
fashion, cells are able to take advantage of a myriad of gain-enhancing
mechanisms in anti-stress gene regulatory networks to achieve robust
homeostatic control (Zhang and Andersen 2007). These include multi-
merization of transcription factors, anti-stress proteins, and enzymes,
cooperative promoter binding, localized positive autoregulation of tran-
scription factors or cofactors, and switch-like signaling such as the three-
tiered MAPK cascade (Huang and Ferrell 1996). While it is essential to
appreciate the role of a high loop gain in anti-stress responses, it is equal-
FIGURE 1. Illustration of the adaptive negative feedback control scheme generalized for anti-stress
gene regulatory networks responsible for maintaining cellular homeostasis.
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ly important to note that the control conferred by the feedback loop may
operate at different capacities as the level of exposure to stressors varies.
In a typical cellular homeostatic control system, the saturable nature of
biochemical interactions and reactions dictates that the steady-state con-
centrations of the controlled variable undergo various phases as the dose
of stressor increases (Zhang and Andersen 2007). Under relatively low-
level exposure, the homeostatic control system operates responsively (i.e.,
the expression of anti-stress genes is upregulated markedly and metabol-
ic enzymes are working at conditions far below saturation.), counteract-
ing the perturbation to the controlled variable. This controlled phase is
superlinear in appearance for the concentration of the controlled vari-
FIGURE 2. Graphic illustration of the hypothesis that hormesis arises from the interplay between the
adaptive response and enhanced energy expenditure required to operate the underlying homeosta-
tic control system. (A, B) Typical steady-state dose response curves for the controlled variable (Y) and
anti-stress gene expression (G), respectively, in an anti-stress gene regulatory network mediated via
negative feedback (Zhang and Andersen 2007). The controlled variable Y transitions through con-
trolled, less controlled, and catastrophic phases. (C, D) If the controlled variable and energy expen-
diture supporting anti-stress gene expression operate linearly but in opposite directions to affect a
particular endpoint response, as described by R = C – αY + βG, then hormesis arises within the adap-
tive controlled region and part of the less controlled region because of the slow rise in Y and sharp
rise in G. Shaded areas in C denote the differences between βG and αY with the sign of the differ-
ence indicated.
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able (Fig. 2A). With intermediate-level exposures, the feedback control
system is less capable of maintaining homeostasis because anti-stress gene
upregulation is approaching maximum induction. In this less controlled
phase, the response curve of the controlled variable gradually changes
into a sublinear response curve (in some cases, there could be a linear
component toward the end), but the rise in the concentration of the con-
trolled variable is still largely contained. Eventually, with sufficiently
intense exposures, the rise of the controlled variable is markedly acceler-
ated, entering a sublinear catastrophic phase. This final phase occurs
because enzymatic reactions in the homeostatic control system responsi-
ble for keeping the controlled variable at safe levels in the cell are finally
moving closer to saturation.
Maintaining controlled variables around their operating concentra-
tions is crucial to normal cellular functions. Increasingly higher expo-
sures to stressors, as illustrated in Fig 2A, are likely to be associated with
transitions of cells through several distinct states of well-being (Fig. 3).
Under exposure to low-dose stressors, very little change in controlled vari-
able concentrations is expected due to strong homeostatic control. This
controlled phase is associated with an adaptive state of the cells to stres-
sors. In this state, cells may not appear much different from the unper-
turbed cells, but there are coordinate changes in gene expression to
maintain cellular homeostasis. Further increase in the level of the stres-
FIGURE 3. Illustrations of cellular state transition as the dose of exposure to stressors increases. Mild
to moderate exposure shifts cells to an adaptive state because the homeostatic control is operating.
Higher exposure moves cells to a stressed state because the limit of homeostatic control is reached.
In this state the innate immune system may be activated leading to inflammatory responses. Cells in
adaptive or stressed state can still return to normal, unstressed state after removal of the stressor.
However, very high doses of stressors are likely to drive cells irreversibly to a toxic state, where apop-
tosis or necrosis occurs. Apoptosis is an active, programmed self-terminating process of the cell in the
event that the cellular damage is too large to be repaired or worth repairing, or the cell’s continued
survival is no longer benefiting the organism as a whole. The above three states are closely associat-
ed with the dose response transition for the controlled variable Y in Fig. 2A (i.e., controlled, less con-
trolled, catastrophic phases).
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sor overwhelms the cellular capacity to handle the stressor. Under this
condition, cells manage to survive, but with many cellular functions like-
ly altered (e.g., cell cycle may be arrested) and innate defense systems
activated (e.g., inflammatory response), thus cells enter a stressed state.
Both the adaptive and stressed states are reversible such that when no
longer exposed to the stressor, cells return to their normal state. At high
stressor doses, the uncurbed rise in the controlled variable leads to cellu-
lar toxicity, which eventually kills the cells by initiating the apoptotic path-
way or through necrosis.
HYPOTHESIS
Under conditions of mild to moderate stressor exposures, cells are at
an adaptive state with slight deviations in the concentrations of controlled
variables. This adaptation does not occur without a cost – the “behind-the-
scene” upregulation of anti-stress genes involved in counteracting the per-
turbations (Fig. 2B) carries some significant energetic costs for the
exposed cells. For example, in E coli, heat shock proteins, which help to
refold denatured proteins to functionally-folded state, are upregulated to
represent 20% of the total protein at 46°C vs. less than 2% at 30°C (Arsene
et al. 2000). It is our hypothesis that this altered energy expenditure occur-
ring in the adaptive cellular state, and possibly in the early state of the
stressed state, may be responsible for hormetic changes in some cellular
endpoints such as rate of proliferation, differentiation, or cell viability.
To illustrate our hypothesis, we can assume that the controlled vari-
able (Y) and the energetic cost incurred from anti-stress gene expression
(G) have opposite influences on a given endpoint response (R). To keep
the model simple, we can further assume the relationship is linear with a
coefficient of α and β, respectively (i.e., R = C – αY + βG, where C is a con-
stant independent of Y and G). Since the adaptive (controlled phase) and
some early part of the stressed (less controlled phase) state is character-
ized by a slow increase in Y but a sharp rise in G (Fig. 2A and 2B), the net
effect on R will be positive under mild to moderate exposure conditions
(Fig. 2C). At very high exposure conditions there is a failure of stress con-
trol. In this situation, the sharp rise in Y and flat change in G produce a
negative net effect on the endpoint response (Fig. 2C). Consequently,
over the whole dose range, the endpoint response would initially increase
and then decrease, displaying a hormetic response profile (Fig. 2D).
AN EXAMPLE: OXIDATIVE STRESS
Living cells are constantly exposed to ROS including superoxide,
hydrogen peroxide, and hydroxyl radicals. Endogenously, ROS are pro-
duced by the aerobic respiratory chain reactions in the mitochondria and
by many biochemical reactions taking place in other organelles.
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Environmental exposure of cells to many chemicals, UV light, and ioniz-
ing radiations can increase ROS production, potentially disrupting cellu-
lar redox balance. Excessive ROS accumulation damages macromole-
cules including lipid, protein, and DNA, leading to membrane structural
changes, protein malfunctions, and genomic instability. To control the
impact of oxidative stressors, cells are equipped with a suite of antioxi-
dant enzymes and small molecules to detoxify excess ROS and maintain
intracellular ROS at appropriate levels. These antioxidant enzymes/mol-
ecules include superoxide dismutase (SOD), catalase (CAT), glutathione
peroxidase (GPx), glutamate cysteine ligase (GCL), glutathione syn-
thetase (GS), and reduced glutathione (GSH), etc.
As with many other control systems, redox homeostasis is maintained
through negative feedback controls. In mammalian cells, cytosolic pro-
tein Keap1 (Kelch-like ECH-associated protein 1) is believed to be
responsible for sensing the level of intracellular ROS (Motohashi and
Yamamoto 2004). At basal conditions, Keap1 promotes ubiquitination
and degradation of Nrf2 (nuclear factor erythroid 2-related factor 2), a
transcription factor that binds to antioxidant response element (ARE).
Nrf2 is thus kept at a low level. When cells are exposed to oxidative stres-
sors, increased ROS oxidize several cysteine residues in Keap1. Oxidized
Keap1 loses its ability to mediate Nrf2 ubiquitination, resulting in stabi-
lization of Nrf2 (Kobayashi et al. 2006). As a consequence, Nrf2 accumu-
lates via de novo synthesis then translocates to the nucleus. In addition,
phosphorylation of Nrf2 by a variety of protein kinases is also believed to
play certain roles in its activation (Yu et al. 2000; Bloom et al. 2002; Huang
et al. 2002; Kang et al. 2002; Pi et al. 2007). Activated Nrf2 binds to AREs
on the promoter regions of many antioxidant genes, upregulating their
expression. The subsequently enhanced antioxidant capacity reduces cel-
lular concentrations of ROS, restoring the redox equilibrium. An inter-
disciplinary group in our laboratory (The Hamner Institutes for Health
Sciences) is beginning to use this oxidative stress gene regulatory network
as a prototype homeostatic system to examine the hypothesis for horme-
sis noted in Fig. 2.
CHLORINE, OXIDATIVE STRESS, AND HORMESIS
While many chemicals can cause oxidative stress, our studies focused
on chlorine as a prototype chemical. Chlorine is widely used in human
society. It is a common water disinfectant, a synthetic intermediate for
many commodity chemicals, and is used for textile and paper bleaching
as well as in pharmaceuticals and cosmetics. Humans are exposed to chlo-
rine in swimming pools, in household cleaners, and in severe cases, from
accidental spills during its transportation (Evans 2005). Inhalation of
chlorine gas can cause a range of respiratory disorders, including pul-
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monary edema, restrictive lung disease, and obstructive disease such as
reactive airway dysfunction syndrome (Lehmler et al. 2005). When dis-
solved in an aqueous condition, such as the surface fluid in the respira-
tory tract, chlorine gas rapidly hydrolyzes to hypochlorous acid (HOCl)
and hydrogen chloride (HCl). In solution, HOCl dissociates to form
hypochlorite ion (OCl–). Sensory irritant responses in the nose were
observed when exposed to less than 1 ppm of chlorine gas, whereas it
takes many times more HCl to produce any irritant effects (Barrow et al.
1977). Thus it is believed that HOCl is the active form of irritant, and is
also the active form of chlorine in bacteria-killing detergents. As a reac-
tive oxidant, HOCl reacts with biological tissues, producing a variety of
oxidized and chlorinated products including chlorinated aromatic amino
acids such as chloro-tyrosine. These products can serve as a local bio-
marker for the exposure of HOCl in tissues.
The predominant mode of action for chlorine in the respiratory tract
appears to be mediated through oxidative stress from HOCl, a strong
ROS. Treatment of mouse macrophages with HOCl dose-dependently
induced nuclear accumulation of Nrf2, the primary transcription factor
mediating antioxidant stress response (Pi et al. 2008a). In addition, many
Nrf2 downstream antioxidant genes were upregulated, including
NADPH: quinone oxidoreductase 1, heme oxygenase-1, GCL, SOD, CAT,
etc (Pi et al. 2008a). HOCl can penetrate the cell membrane to react
directly with GSH (Winterbourn and Brennan 1997; Pullar et al. 1999).
Therefore, the initial cellular response to HOCl included a decrease in
intracellular GSH (Pi et al. 2008a). However, as GCL and GS, the two
enzymes responsible for de novo GSH synthesis are upregulated through
Nrf2 activation, decreases in the intracellular GSH level can be reversed,
and eventually GSH may increase above control levels.
Plotting intracellular GSH levels vs. different HOCl concentrations
shows a hormetic response at 12 hour after the onset of HOCl exposure
(Fig. 4A). At HOCl concentrations less than 0.7 mM, GSH are above the
basal level; however, further increases in HOCl concentration result in a
decrease in GSH levels, and at 2.8 mM of HOCl, intracellular GSH
decreases to below the basal level. This hormetic GSH response can be
attributed to a similar hormetic dose response profile of GCLC, the cat-
alytic subunit of GCL. The peak mRNA level of GCLC shows a maximum
response at 0.7 mM of HOCl (Fig. 4B), and greater HOCl concentrations
somehow suppress GCLC expression. A similar hormetic response in gene
expression was also observed with other antioxidant genes such as NQO-1
(Fig. 4C). The repression of gene expression at high HOCl concentrations
is not due to cytotoxicity as at the same concentration 90% of the cells are
still viable, and other genes, not themselves involved in antioxidant
response, are upregulated (data not shown). Importantly, cell viability, as
measured by MTT assay, also displays a hormetic dose response. Exposure
9
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to low concentrations of HOCl causes up to 20% enhancement of cell via-
bility whereas high concentrations reduce viability (Fig. 4D). When com-
paring the hormetic zones in all these responses (Fig. 4A – 4D), it appears
that hormesis occurs in approximately the same dose range regardless of
the endpoint. These nearly overlapping hormetic zones coincide with the
adaptive cellular state, as the cell population seems to survive well in the
dose range. The hormetic viability response was also observed in cells pre-
treated with a moderate concentration of oxidants. As indicated in Fig.
4D, a previous exposure to a low concentration of HOCl or tert-butylhy-
droquinone shifts the dose response curve to the right for subsequent
HOCl treatment, while preserving the nonmonotonic nature. It needs to
be noted that the hormetic change in cell viability observed with HOCl
appears to represent a “conserved” response profile associated with expo-
sure to oxidative stressors. For instance, arsenic, an oxidative stressor that
can activate Nrf2-mediated adaptive response (Pi et al. 2003), also increas-
es cell viability at low doses and decreases it at high doses (Pi et al. 2008b).
FIGURE 4. Hormetic responses in RAW 264.7 mouse macrophages treated with HOCl.
(A) Intracellular GSH levels at 12 h after HOCl treatment. (B, C) Gene expression of GCLC and
NQO-1, respectively, at 6 h after HOCl treatment. (D) Cell viability at 24 h (measured with MTT
assay) after HOCl treatment in the absence of any pretreatment (dashed line) or in the presence of
previous exposure to 0.7 mM HOCl (dotted line) or 5 µM tert-butylhydroquinone (solid line). Part
of the data are adapted from (Pi et al. 2008a). * indicates P<0.05 compared with controls. 
10
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A similar effect was also observed with hydrogen peroxide in yeasts
(Davies et al. 1995).
Nel has hypothesized that under exposure to increasing concentra-
tions of oxidative stressors, there is a hierarchical activation of different
types of cellular pathways/responses (Xiao et al. 2003). With no or
extremely low-level oxidative exposures, cells maintain their normal func-
tions without any significant alterations. A mild or moderate oxidative
exposure will activate the Nrf2-mediated antioxidant response by induc-
ing phase II and antioxidant enzymes, which are responsible for keeping
ROS at relatively low levels. This tier I response is adaptive in nature, and
cells can survive without markedly altered functions. A further increase in
the stressor dose starts to overwhelm the Nrf2-mediated antioxidant con-
trol system. As a result, oxidative stressors move the cell down the
response hierarchy, activating tier II NF-kB-mediated inflammatory
response. Additional increase in the oxidative stressor dose will drive cells
into tier III response, which activates apoptotic pathways leading to cell
death. Our findings with macrophages treated with HOCl are consistent
with this sequence of responses. HOCl at concentrations less than 0.7 mM
activates antioxidant gene expression. At higher concentrations antioxi-
dant gene expression is repressed while inflammatory gene markers such
as IL-6 and IL-1β are activated (Woods et al. 2008). At even greater HOCl
doses, reduced cell viability is observed (Fig. 4D), indicating cells may be
entering tier III cytotoxic phase. The hormetic change in cell viability
observed at relatively low HOCl concentrations coincides with tier I
antioxidant response, suggesting that hormesis is closely coupled to the
activation of adaptive homeostatic mechanisms.
CONCLUSIONS
The phenomena of hormesis and toxicity thresholds are likely relat-
ed to activation of adaptive pathways responsible for cellular and physio-
logical homeostasis. Before hormesis can be used on a large scale in risk
assessment, several prototype chemicals and adaptive response models
exemplifying hormetic responses need to be well-characterized to under-
stand the underlying homeostatic responses. These prototypes may
include irritant gas such as chlorine, discussed here, heavy metals, as well
as receptor-mediated responses from hepatic enzyme inducers or other
transcriptionally active xenobiotics. A chemical is likely to impinge upon
more than one toxicity pathway, which is interconnected into responsive
networks within the cell, as suggested by the tiered responses observed
with HOCl. Therefore, the overall cellular responses to a particular per-
turbation are governed by the systems-level behaviors of the networks.
Characterization of the underlying mechanisms of hormetic responses is
an interdisciplinary effort requiring integration of dosimetry, in vitro and
in vivo measurement of various endpoints, functional genomic mapping
11
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of the underlying biochemical pathways, and lastly, computational for-
mulation of the adaptive pathways and networks that can test dose
response hypotheses quantitatively. In the absence of well-developed
examples revealing the systems-level mechanistic basis for hormesis and
nonmonotonic responses, low-dose extrapolations employed in risk
assessments will have to stay wedded to the low-dose linear and threshold
linear methodologies that are now favored. The time has come to move
from commenting on the frequency of observing hormesis to a commit-
ment to understanding the biological mechanisms that control these fre-
quently hormetic dose response relationships.
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